Islam Saqib — SEC Form 4 filings

SEC reporting owner CIK 1575408. 16 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2024-05-23 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SpringWorks Therapeutics, Inc. (SWTX)Chief Executive Officer, Director1118 legs · 284,000 sh · $13,594,28617
ARS Pharmaceuticals, Inc. (SPRY)Director33
Passage BIO, Inc. (PASG)Director22

Form 4 filings — Islam Saqib

FiledFormIssuerReported transactionsSource
2026-06-264ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-07-024SpringWorks Therapeutics, Inc. (SWTX)Disposition to issuer (D): 954,869 · Disposition to issuer (D): 579,749 (derivative) · Disposition to issuer (D): 22,760 (derivative) · Disposition to issuer (D): 769,804 (derivative) · Disposition to issuer (D): 176,411 (derivative) · Disposition to issuer (D): 325,000 (derivative) · +3 moreEDGAR
2025-06-274ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-05-304Passage BIO, Inc. (PASG)Grant/award (A): 201,857 (derivative) @ $0EDGAR
2025-03-054SpringWorks Therapeutics, Inc. (SWTX)Tax withholding (F): 30,756 @ $53.41 · Sale (S): 11,800 @ $52.97 · Sale (S): 23,600 @ $54.24 · Sale (S): 11,600 @ $55.15 · Sale (S): 1,400 @ $56.13 · Sale (S): 600 @ $56.89EDGAR
2025-02-244SpringWorks Therapeutics, Inc. (SWTX)Sale (S): 24,260 @ $60.10 · Sale (S): 5,068 @ $61.24EDGAR
2025-02-194SpringWorks Therapeutics, Inc. (SWTX)Sale (S): 10,672 @ $59.92EDGAR
2025-02-144SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 85,309 @ $0 · Tax withholding (F): 13,186 @ $59.28EDGAR
2025-02-124SpringWorks Therapeutics, Inc. (SWTX)Sale (S): 48,000 @ $53.30EDGAR
2025-01-144SpringWorks Therapeutics, Inc. (SWTX)Grant/award (A): 74,834 @ $0 · Grant/award (A): 109,329 (derivative) @ $0EDGAR
2025-01-074SpringWorks Therapeutics, Inc. (SWTX)Tax withholding (F): 13,469 @ $38.19 · Tax withholding (F): 12,872 @ $38.19 · Tax withholding (F): 12,359 @ $38.86EDGAR
2024-12-044SpringWorks Therapeutics, Inc. (SWTX)Sale (S): 45,011 @ $41.33 · Sale (S): 3,989 @ $41.85EDGAR
2024-09-044SpringWorks Therapeutics, Inc. (SWTX)Sale (S): 32,400 @ $40.10 · Sale (S): 9,908 @ $41.10 · Sale (S): 6,692 @ $42.07EDGAR
2024-06-244ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-054SpringWorks Therapeutics, Inc. (SWTX)Sale (S): 33,240 @ $39.40 · Sale (S): 8,760 @ $40.57 · Sale (S): 6,600 @ $41.40 · Sale (S): 400 @ $42.09EDGAR
2024-05-234Passage BIO, Inc. (PASG)Grant/award (A): 47,693 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1575408 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →